Prefrontal Cortical Substrate for Performance Monitoring in Pediatric Obsessive-Compulsive Disorder: Atypical Development and Implications for Treatment Response

被引:0
|
作者
Fitzgerald, Kate [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
61.1
引用
收藏
页码:S113 / S114
页数:2
相关论文
共 50 条
  • [21] Atypical Development of Neural Substrate for Error-processing in Pediatric Obsessive Compulsive Disorder
    Fitzgerald, Kate
    Liu, Yanni
    Welsh, Robert
    Hanna, Gregory
    Taylor, Stephan
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S239 - S240
  • [22] Multimodal Performance Monitoring in Patients With Obsessive-Compulsive Disorder
    Taylor, Stephan F.
    Fitzgerald, Kate D.
    Abelson, James L.
    BIOLOGICAL PSYCHIATRY, 2016, 80 (07) : 507 - 508
  • [23] Cortical Abnormalities Associated with Pediatric and Adult Obsessive-Compulsive Disorder: Findings from the Enigma Obsessive-Compulsive Disorder Working Group
    Boedhoe, Premika
    Schmaal, Lianne
    Arnold, Paul
    Benedetti, Francesco
    Beucke, Jan
    Cheng, Yuqi
    Denys, Damiaan
    Fitzgerald, Kate
    Gruner, Patricia
    Hoexter, Marcelo
    Huyser, Chaim
    James, Anthony
    Koch, Kathrin
    Kwon, Jun Soo
    Lazaro, Luisa
    Mataix-Cols, David
    Menchon, Jose
    Nakamae, Takashi
    Nakao, Tomohiro
    Nurmi, Erika
    Reddy, Y. C. Janardhan
    Simpson, H. Blair
    Soreni, Noam
    Spalletta, Gianfranco
    Tolin, David
    Walitza, Susanne
    Wang, Zhen
    Thompson, Paul
    Stein, Dan
    van den Heuvel, Odile
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S375 - S376
  • [24] Specificity of performance monitoring changes in obsessive-compulsive disorder
    Endrass, Tanja
    Ullsperger, Markus
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 124 - 138
  • [25] Neuropsychology of obsessive-compulsive disorder: a review and treatment implications
    Greisberg, S
    McKay, D
    CLINICAL PSYCHOLOGY REVIEW, 2003, 23 (01) : 95 - 117
  • [26] The role of atypical antipsychotics in obsessive-compulsive disorder resistant to treatment
    Bolos, A.
    Chirita, R.
    Chirita, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S590 - S591
  • [27] THE PSYCHOPHARMACOLOGY OF OBSESSIVE-COMPULSIVE DISORDER - IMPLICATIONS FOR TREATMENT AND PATHOGENESIS
    MCDOUGLE, CJ
    GOODMAN, WK
    LECKMAN, JF
    PRICE, LH
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1993, 16 (04) : 749 - 766
  • [28] Predictors of Parental Accommodation in Pediatric Obsessive-Compulsive Disorder: Findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) Trial
    Flessner, Christopher A.
    Freeman, Jennifer B.
    Sapyta, Jeffrey
    Garcia, Abbe
    Franklin, Martin E.
    March, John S.
    Foa, Edna
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (07): : 716 - 725
  • [29] Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder
    Rosenberg, DR
    Averbach, DH
    OHearn, KM
    Seymour, AB
    Birmaher, B
    Sweeney, JA
    ARCHIVES OF GENERAL PSYCHIATRY, 1997, 54 (09) : 831 - 838
  • [30] Pharmacogenetics of Antidepressant Treatment Response in Obsessive-Compulsive Disorder
    Zai, Gwyneth
    Cappi, Carolina
    Goncalves, Vanessa
    Shavitt, Roseli
    Miguel, Euripedes Constantino
    Richter, Margaret A.
    Kennedy, James L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 8 - 9